Could a simple blood test track nerve damage? a study investigates NT-3 levels in neuropathy.
NCT ID NCT05011006
First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time
Summary
This study measures levels of a protein called NT-3 in the blood of people with peripheral neuropathy or Charcot-Marie-Tooth disease. Researchers will compare these levels with measures of muscle strength, mobility, and daily function. The goal is to see whether NT-3 levels correlate with how well the nerves and muscles are working.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If a link is found, NT-3 levels might become a useful marker for tracking neuropathy severity or guiding future treatments.
- What could go wrong
- This is a very small observational study with only 8 participants, so any patterns seen may not apply to larger groups. It does not test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHARCOT-MARIE-TOOTH DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new antibody calm the immune attack in CIDP?
- Wearable insoles warn of foot pressure to stop diabetic ulcers
- New bladder cancer drug aims to fight tumors without harming nerves
- Acupuncture with a jolt: could needles shield nerves from chemo?
- Could a simple device ease nerve pain in Charcot-Marie-Tooth?
- Acupuncture needles aim to stop Chemo's nerve pain